Autopsy report · NCT01872377

Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“No longer recruiting patients to this study”

The sponsor’s own words in the registry.

Life of this trial

Registered 9 months before it started.
Ran for about 4 years 10 months before it stopped.
7 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Ottawa Hospital Research Institute
Sponsor type: University, hospital or other
Conditions: Pancreatic Carcinoma Non-resectable
Interventions: CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost
Participants: 7
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.